Learn who big data applies to the healthcare industry, the challenges of healthcare data analytics, and how Xevant can provide big data management.
It’s no surprise that the United States spends more on healthcare than any other developed nation, and costs are expected to continue to climb.
Read on to learn about PBM rebate transparency, pricing models, and how Xevant can change the rebate game.
Even in the wake of the pandemic, increases in prescription drug prices continue to “outpace inflation,” according to a recent AARP…
According to an oft-cited study by the World Health Organization (WHO), medication non-adherence can impact a patient’s health outcomes…
From unexpected mergers to the onslaught of specialty drugs, the pharmaceutical industry has changed drastically over the last several…
The drug industry is faced with many challenges one of the biggest impediments is the lack of prescription compliance.
Pharmacy is growing at a 3x faster rate than medical but typically does not get nearly as much attention- until now.
With 125,000 annual deaths and $300 billion in cost, identifying and improving shortfalls that cause medication nonadherence is vital.
Biologics are often held partially responsible for rising drug costs in the U.S. But, with biosimilars, that’s changing.